Form 8-K CHEMBIO DIAGNOSTICS, For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Chembio Diagnostics (CEMI) Reports Q2 GAAP Loss of $0.86/Share
August 11, 2016 8:34 AM EDTChembio Diagnostics (NASDAQ: CEMI) reported Q2 EPS of ($0.86), versus ($0.07) reported last year. Revenue for the quarter came in at $3.27 million, versus $6.72 million reported last year.
The net loss in the 2016 period includes a tax provision for the recording of a valuation allowance on... More
